Get startedLog in
    Picture of Contineum Therapeutics logo

    CTNM — Contineum Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Contineum Therapeutics Provides Update On Phase 1B Positron Emission Tomography Trial Of Pipe-791

    Picture of Contineum Therapeutics logoContineum Therapeutics
    25/06/2025 13:17
    June 25 (Reuters) - Contineum Therapeutics Inc CTNM.O:

CONTINEUM THERAPEUTICS PROVIDES UPDATE ON PHASE 1B POSITRON EMISSION TOMOGRAPHY (PET) TRIAL OF PIPE-791

Source text: ID:nBw68VwLa

Further company coverage: CTNM.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Contineum Therapeutics

    See all news